Breast radiation therapy under COVID-19 pandemic resource constraints—Approaches to defer or shorten treatment from a comprehensive cancer center in the United States Review
| Authors: | Braunstein, L. Z.; Gillespie, E. F.; Hong, L.; Xu, A.; Bakhoum, S. F.; Cuaron, J.; Mueller, B.; McCormick, B.; Cahlon, O.; Powell, S.; Khan, A. J. |
| Review Title: | Breast radiation therapy under COVID-19 pandemic resource constraints—Approaches to defer or shorten treatment from a comprehensive cancer center in the United States |
| Abstract: | Purpose: Breast radiation therapy accounts for a significant proportion of patient volume in contemporary radiation oncology practice. In the setting of anticipated resource constraints and widespread community infection with SARS-CoV-2 during the COVID-19 pandemic, measures for balancing both infectious and oncologic risk among patients and providers must be carefully considered. Here, we present evidence-based guidelines for omitting or abbreviating breast cancer radiation therapy, where appropriate, in an effort to mitigate risk to patients and optimize resource utilization. Methods and Materials: Multidisciplinary breast cancer experts at a high-volume comprehensive cancer center convened contingency planning meetings over the early days of the COVID-19 pandemic to review the relevant literature and establish recommendations for the application of hypofractionated and abbreviated breast radiation regimens. Results: Substantial evidence exists to support omitting radiation among certain favorable risk subgroups of patients with breast cancer and for abbreviating or accelerating regimens among others. For those who require either whole-breast or postmastectomy radiation, with or without coverage of the regional lymph nodes, a growing body of literature supports various hypofractionated approaches that appear safe and effective. Conclusions: In the setting of a public health emergency with the potential to strain critical healthcare resources and place patients at risk of infection, the parsimonious application of breast radiation therapy may alleviate a significant clinical burden without compromising long-term oncologic outcomes. The judicious and personalized use of immature study data may be warranted in the setting of a competing mortality risk from this widespread pandemic. © 2020 The Author(s) |
| Keywords: | cancer surgery; review; united states; cancer radiotherapy; breast cancer; mastectomy; evidence based practice; health care utilization; cancer center; lymph node; high risk population; accelerated partial breast irradiation; pandemic; hypofractionated radiotherapy; human; priority journal; radiation oncologist; high volume hospital; multidisciplinary team; breast radiotherapy; coronavirus disease 2019 |
| Journal Title: | Advances in Radiation Oncology |
| Volume: | 5 |
| Issue: | 4 |
| ISSN: | 2452-1094 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-07-01 |
| Start Page: | 582 |
| End Page: | 588 |
| Language: | English |
| DOI: | 10.1016/j.adro.2020.03.013 |
| PROVIDER: | scopus |
| PMCID: | PMC7118660 |
| PUBMED: | 32292842 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 September 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work